FDA GRAS Notice 1288 Amendment for Steviol Glycosides

The Food and Drug Administration (FDA) has posted an amendment to Generally Recognized As Safe (GRAS) Notice 1288, which pertains to enzyme-modified steviol glycosides. This filing indicates a modification or update to a previously submitted GRAS notification by the manufacturer, HFP.

As this is an amendment to a GRAS notice, it is part of the manufacturer's self-affirmation process, with the FDA reviewing the submission. Regulated entities, particularly food manufacturers utilizing steviol glycosides, should be aware of potential updates to the safety information or intended uses associated with this ingredient. No immediate compliance actions are mandated by this posting, but it serves as an informational update on the regulatory status of the ingredient.